Related Articles
Adrenalectomy may increase survival of patients with adrenal metastases
Oncological outcomes classified according to metastatic lesions in the era of molecular targeted drugs for metastatic renal cancer
GLI2 expression levels in radical nephrectomy specimens as a predictor of disease progression in patients with metastatic clear cell renal cell carcinoma following treatment with sunitinib
Predictive value of the modified Glasgow Prognostic Score for the therapeutic effects of molecular‑targeted drugs on advanced renal cell carcinoma
Progression‑free survival of first‑line treatment with molecular‑targeted therapy may be a meaningful intermediate endpoint for overall survival in patients with metastatic renal cell carcinoma